These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34391137)

  • 1. Isolation and characterization of thermal degradation impurity in brimonidine tartrate by HPLC, LC-MS/MS, and 2DNMR.
    Baksam V; Nimmakayala S; Devineni SR; Muchumarri RMR; Shandilya S; Kumar P
    J Pharm Biomed Anal; 2021 Oct; 205():114297. PubMed ID: 34391137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and Characterization of an Unknown Process-Related Impurity in Furosemide and Validation of a New HPLC Method.
    Xu A; Xue Y; Zeng Y; Li J; Zhou H; Wang Z; Chen Y; Chen H; Jin J; Zhuang T
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, isolation and characterization of a new degradation product in sultamicillin drug substance.
    Kumar VJ; Gupta PB; Kumar KS; Ray UK; Sreenivasulu B; Kumar GS; Rao KR; Sharma HK; Mukkanti K
    J Pharm Biomed Anal; 2011 Feb; 54(3):582-7. PubMed ID: 20934824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification, isolation and characterization of potential process-related impurity and its degradation product in vildagliptin.
    Kumar N; Devineni SR; Singh G; Kadirappa A; Dubey SK; Kumar P
    J Pharm Biomed Anal; 2016 Feb; 119():114-21. PubMed ID: 26678178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, isolation, identification and characterization of new process-related impurity in isoproterenol hydrochloride by HPLC, LC/ESI-MS and NMR.
    Kumar N; Devineni SR; Gajjala PR; Dubey SK; Kumar P
    J Pharm Anal; 2017 Dec; 7(6):394-400. PubMed ID: 29404065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation and structural characterization of unknown impurity in vancomycin by two-dimensional preparative liquid chromatography, LC-MS and NMR.
    Wang X; Qiu Y; Wen H; Weng R; Chen D; Liu H
    J Pharm Biomed Anal; 2023 Aug; 232():115403. PubMed ID: 37120972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Five Oxidative Degradation Impurities and One Process Impurity of Suvorexant Drug Substance by LC-MS/MS, HR-MS and 1D, 2D NMR: Validation of Suvorexant Drug Substance and Process Impurities by HPLC and UPLC.
    Rajana N; Devi DR; Kumar Reddy DN; Babu JM; Basavaiah K; Balakumaran K
    J Chromatogr Sci; 2020 Apr; 58(5):433-444. PubMed ID: 32134104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Structural Elucidation of New Process Impurity in Testosterone.
    Gupte V; Luthra U; Desai N
    J Chromatogr Sci; 2018 May; 56(5):403-408. PubMed ID: 29554236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Novel Impurity of Ziprasidone.
    Murkute SR; Singh GP; Vasantharaju SG; Bhat K; Godbole HM; Upadhyay PR; Trivedi A
    J Pharm Biomed Anal; 2022 Jan; 207():114416. PubMed ID: 34678557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-preparative isolation and structural elucidation of an impurity in citalopram by LC/MS/MS.
    Raman B; Sharma BA; Ghugare PD; Karmuse PP; Kumar A
    J Pharm Biomed Anal; 2009 Oct; 50(3):377-83. PubMed ID: 19556091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation.
    Thomas S; Mathela CS; Agarwal A; Paul SK
    J Pharm Biomed Anal; 2011 Sep; 56(2):423-8. PubMed ID: 21676571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of two unknown impurities in roxithromycin by 2D LC-QTOF/MS/MS and NMR.
    Wang J; Zhou J; Xu Y; Zhu B; Jin Y
    J Pharm Biomed Anal; 2020 May; 184():113196. PubMed ID: 32113121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four process-related potential new impurities in ticagrelor: Identification, isolation, characterization using HPLC, LC/ESI-MS(n), NMR and their synthesis.
    Kumar N; Devineni SR; Gajjala PR; Gupta DK; Bhat S; Kumar R; Dubey SK; Kumar P
    J Pharm Biomed Anal; 2016 Feb; 120():248-60. PubMed ID: 26760243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, identification, characterization, synthesis and quality control strategy of new process-related impurities in ambrisentan.
    Feng WD; Zhuo SM; Zhang FL
    J Pharm Biomed Anal; 2019 Feb; 165():325-337. PubMed ID: 30579233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and structural elucidation of two impurities from a diacerein bulk drug.
    Ashok C; Golak M; Adwait D; Krishna V; Himani A; Umesh P; Amol G; Srinivas S; Sharad M; Deepali J; Atul C
    J Pharm Biomed Anal; 2009 Feb; 49(2):525-8. PubMed ID: 19131202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of new impurity in didanosine.
    Srinivasa Rao DV; Srinivas N; Bharathi Ch; Prasad ChS; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Nov; 45(3):516-20. PubMed ID: 17624711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, identification and characterization of two novel process-related impurities in olanzapine.
    Zhuang T; Zhang W; Cao L; He K; Wang Y; Li J; Chen L; Liu B; Zhang G
    J Pharm Biomed Anal; 2018 Apr; 152():188-196. PubMed ID: 29414012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of unknown impurities in Coenzyme Q
    Deng Y; Chen X; Wang L; Peng X; Lin M
    J Pharm Biomed Anal; 2019 Oct; 175():112771. PubMed ID: 31330281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.